Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients

The BK virus (BKV) causes severe hemorrhagic cystitis in hematopoietic stem cell transplant (HSCT) recipients. To eliminate reactivated BKV, symptomatic patients can be treated with a reduction of the immunosuppressive therapy, with the antiviral drug cidofovir, or with virus-specific T cells (VSTs)...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Michael Koldehoff, Britta Eiz-Vesper, Britta Maecker-Kolhoff, Nina K. Steckel, Ulf Dittmer, Peter A. Horn, Monika Lindemann
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2023-04-01
Saila:	Vaccines
Gaiak:	BK virus hematopoietic stem cell transplantation treatment with virus-specific T cells immunosuppression cidofovir JC virus
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/11/4/845
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!